Targeting DNA repair in precision medicine

被引:10
作者
Beggs, Reena [1 ]
Yang, Eddy S. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Sch Med, Dept Radiat Oncol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Sch Med, Hugh Kaul Precis Med Inst, Birmingham, AL 35294 USA
来源
DNA REPAIR | 2019年 / 115卷
关键词
ABDOMINAL RADIATION-THERAPY; ADVANCED SOLID MALIGNANCIES; NUCLEOTIDE EXCISION-REPAIR; DEPENDENT PROTEIN-KINASE; DOUBLE-STRAND BREAKS; CELL LUNG-CANCER; HOMOLOGOUS RECOMBINATION; PHASE-I; VELIPARIB ABT-888; DAMAGE RESPONSE;
D O I
10.1016/bs.apcsb.2018.10.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Precision medicine is an emerging treatment paradigm that aims to find the right therapy at the right time based on an individual's unique genetic background, environment, and lifestyle. One area of precision medicine that has had success is targeting DNA repair in cancer. DNA is exposed to constant stress and there are repair mechanisms in place to maintain genetic integrity. These repair mechanisms can be targeted as a treatment strategy. In this chapter, we will focus on current efforts to target DNA repair pathways as part of precision oncology-based treatments.
引用
收藏
页码:135 / 155
页数:21
相关论文
共 95 条
[21]   Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy [J].
Farmer, H ;
McCabe, N ;
Lord, CJ ;
Tutt, ANJ ;
Johnson, DA ;
Richardson, TB ;
Santarosa, M ;
Dillon, KJ ;
Hickson, I ;
Knights, C ;
Martin, NMB ;
Jackson, SP ;
Smith, GCM ;
Ashworth, A .
NATURE, 2005, 434 (7035) :917-921
[22]   Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule [J].
Ghebeh, Hazem ;
Lehe, Cynthia ;
Barhoush, Eman ;
Al-Romaih, Khaldoon ;
Tulbah, Asma ;
Al-Alwan, Monther ;
Hendrayani, Siti-Faujiah ;
Manogaran, Pulicat ;
Alaiya, Ayodele ;
Al-Tweigeri, Taher ;
Aboussekhra, Abdelilah ;
Dermime, Said .
BREAST CANCER RESEARCH, 2010, 12 (04)
[23]   Preclinical Evaluation of the WEE1 Inhibitor MK-1775 as Single-Agent Anticancer Therapy [J].
Guertin, Amy D. ;
Li, Jing ;
Liu, Yaping ;
Hurd, Melissa S. ;
Schuller, Alwin G. ;
Long, Brian ;
Hirsch, Heather A. ;
Feldman, Igor ;
Benita, Yair ;
Toniatti, Carlo ;
Zawel, Leigh ;
Fawell, Stephen E. ;
Gilliland, D. Gary ;
Shumway, Stuart D. .
MOLECULAR CANCER THERAPEUTICS, 2013, 12 (08) :1442-1452
[24]   Immune checkpoint inhibition in ovarian cancer [J].
Hamanishi, Junzo ;
Mandai, Masaki ;
Konishi, Ikuo .
INTERNATIONAL IMMUNOLOGY, 2016, 28 (07) :339-348
[25]   WEE1 Kinase Targeting Combined with DNA-Damaging Cancer Therapy Catalyzes Mitotic Catastrophe [J].
Hamer, Philip C. De Witt ;
Mir, Shahryar E. ;
Noske, David ;
Van Noorden, Cornelis J. F. ;
Wuerdinger, Tom .
CLINICAL CANCER RESEARCH, 2011, 17 (13) :4200-4207
[26]   Targeting CDK4/6 in patients with cancer [J].
Hamilton, Erika ;
Infante, Jeffrey R. .
CANCER TREATMENT REVIEWS, 2016, 45 :129-138
[27]   RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer [J].
He, Wei-Ling ;
Li, Yu-Huang ;
Hou, Wei-Jian ;
Ke, Zun-Fu ;
Chen, Xin-Lin ;
Lu, Li-Ya ;
Cai, Shi-Rong ;
Song, Wu ;
Zhang, Chang-Hua ;
He, Yu-Long .
WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (29) :10094-10107
[28]   DNA repair pathways as targets for cancer therapy [J].
Helleday, Thomas ;
Petermann, Eva ;
Lundin, Cecilia ;
Hodgson, Ben ;
Sharma, Ricky A. .
NATURE REVIEWS CANCER, 2008, 8 (03) :193-204
[29]   Direct imaging of human Rad51 nucleoprotein dynamics on individual DNA molecules [J].
Hilario, Jovencio ;
Amitani, Ichiro ;
Baskin, Ronald J. ;
Kowalczykowski, Stephen C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (02) :361-368
[30]   Parp-1 protects homologous recombination from interference by Ku and ligase IV in vertebrate cells [J].
Hochegger, H ;
Dejsuphong, D ;
Fukushima, T ;
Morrison, C ;
Sonoda, E ;
Schreiber, V ;
Zhao, GY ;
Saberi, A ;
Masutani, M ;
Adachi, N ;
Koyama, H ;
de Murcia, G ;
Takeda, S .
EMBO JOURNAL, 2006, 25 (06) :1305-1314